Literature DB >> 33477882

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.

Jacek Marzec1, Helen Ross-Adams1, Stefano Pirrò1, Jun Wang1, Yanan Zhu2, Xueying Mao2, Emanuela Gadaleta1, Amar S Ahmad3, Bernard V North3, Solène-Florence Kammerer-Jacquet2, Elzbieta Stankiewicz2, Sakunthala C Kudahetti2, Luis Beltran4, Guoping Ren5, Daniel M Berney2,4, Yong-Jie Lu2, Claude Chelala1,6.   

Abstract

Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.

Entities:  

Keywords:  RNAseq; data integration; mRNA; prostate cancer; transcriptomic; tumorigenesis

Year:  2021        PMID: 33477882      PMCID: PMC7838904          DOI: 10.3390/cancers13020345

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  80 in total

1.  In silico functional profiling of individual prostate cancer tumors: many genes, few functions.

Authors:  Ivan P Gorlov; Jinyoung Byun; Christopher J Logothetis
Journal:  Cancer Genomics Proteomics       Date:  2012 May-Jun       Impact factor: 4.069

2.  Strong decrease in biotin content may correlate with metabolic alterations in colorectal adenocarcinoma.

Authors:  C L Cherbonnel-Lasserre; G Linares-Cruz; J P Rigaut; L Sabatier; B Dutrillaux
Journal:  Int J Cancer       Date:  1997-09-04       Impact factor: 7.396

3.  CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR.

Authors:  Ranjana Mitra; Oscar B Goodman
Journal:  Prostate       Date:  2015-01-13       Impact factor: 4.104

4.  Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.

Authors:  Deshui Jia; Ying Jing; Zhenfeng Zhang; Li Liu; Jie Ding; Fangyu Zhao; Chao Ge; Qifeng Wang; Taoyang Chen; Ming Yao; Jinjun Li; Jianren Gu; Xianghuo He
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

5.  Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells.

Authors:  Cathrine Fladeby; Shailly N Gupta; Nicolas Barois; Petri I Lorenzo; Jeremy C Simpson; Fahri Saatcioglu; Oddmund Bakke
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

6.  Synaptopodin-2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration.

Authors:  FuiBoon Kai; James P Fawcett; Roy Duncan
Journal:  Oncotarget       Date:  2015-05-10

7.  Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.

Authors:  Prabhakar Rajan; Jacqueline Stockley; Ian M Sudbery; Janis T Fleming; Ann Hedley; Gabriela Kalna; David Sims; Chris P Ponting; Andreas Heger; Craig N Robson; Rhona M McMenemin; Ian D Pedley; Hing Y Leung
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

8.  Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.

Authors:  Yuannv Zhang; Zhaoping Qiu; Lin Wei; Ruqi Tang; Baofeng Lian; Yingjun Zhao; Xianghuo He; Lu Xie
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

Authors:  Danielle Crawley; Ashish Chandra; Massimo Loda; Cheryl Gillett; Paul Cathcart; Ben Challacombe; Gary Cook; Declan Cahill; Aida Santa Olalla; Fidelma Cahill; Gincy George; Sarah Rudman; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2017-07-21       Impact factor: 4.430

10.  Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.

Authors:  Keisuke Takeda; Noboru Hara; Tsutomu Nishiyama; Masayuki Tasaki; Fumio Ishizaki; Yoshihiko Tomita
Journal:  BMC Cancer       Date:  2016-05-25       Impact factor: 4.430

View more
  6 in total

Review 1.  From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.

Authors:  Ekaterina Nevedomskaya; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 2.  Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Authors:  Nuria Gómez-Cebrián; José Luis Poveda; Antonio Pineda-Lucena; Leonor Puchades-Carrasco
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

3.  Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction.

Authors:  Giulia Dal Santo; Marco Frasca; Gloria Bertoli; Isabella Castiglioni; Claudia Cava
Journal:  Comput Struct Biotechnol J       Date:  2022-02-07       Impact factor: 7.271

4.  An enhanced Genetic Folding algorithm for prostate and breast cancer detection.

Authors:  Mohammad A Mezher; Almothana Altamimi; Ruhaifa Altamimi
Journal:  PeerJ Comput Sci       Date:  2022-06-21

5.  Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.

Authors:  Kobe C Yuen; Ben Tran; Angelyn Anton; Habib Hamidi; Anthony J Costello; Niall M Corcoran; Nathan Lawrentschuk; Natalie Rainey; Marie C G Semira; Peter Gibbs; Sanjeev Mariathasan; Shahneen Sandhu; Edward E Kadel
Journal:  Prostate       Date:  2022-04-18       Impact factor: 4.012

6.  Prostate cancer in omics era.

Authors:  Nasrin Gholami; Amin Haghparast; Iraj Alipourfard; Majid Nazari
Journal:  Cancer Cell Int       Date:  2022-09-05       Impact factor: 6.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.